Want to see AU:SKN full AI Analyst Report?
Skin Elements Limited (SKN) AI Stock Analysis
Top Page
Skin Elements Limited
(ASX:SKN)
The score is primarily constrained by weak financial performance—sharp revenue decline, severe ongoing losses, and a return to negative operating cash flow in 2026. Valuation inputs are also not supportive due to a negative P/E and no dividend yield data. Technical analysis cannot be meaningfully assessed because key indicators were not provided, so it does not offset the fundamental risk.
Skin Elements Limited (SKN) vs. iShares MSCI Australia ETF (EWA)
Not enough price history over this period.
- Market Cap
- AUD 6.97M
- Dividend Yield
- ―
- Average Volume (3M)
- ―
- Price to Earnings (P/E)
- -0.4
- Beta (1Y)
- 2.03
- Revenue Growth
- -50.64%
- EPS Growth
- -72.00%
- Country
- Australia
- Employees
- 5
- Sector
- Consumer Defensive
- Sector Strength
- 62
- Industry
- Household & Personal Products
Skin Elements Limited Business Overview & Revenue Model
Company Description
Headquartered in West Perth, Australia, Skin Elements Limited is a natural skincare enterprise established in 2015. The company specializes in the development, manufacturing, distribution, and retail of natural, organic, health, and wellness products...
How the Company Makes Money
null
Skin Elements Limited Financial Statement Overview
Summary
Financial statements indicate very weak fundamentals: revenue is shrinking sharply (2026 down ~32% YoY), the company remains deeply unprofitable with extremely large losses relative to sales, and operating cash flow turned sharply negative again in 2026 (~-2.6m). While gross margins are strong and equity returned to positive in 2026 (an improvement from prior negative equity), the overall profile is still dominated by persistent losses and unstable cash generation.
Income Statement
18Very NegativeBalance Sheet
34NegativeCash Flow
15Very Negative| Breakdown | TTM | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 231.95K | 231.95K | 469.96K | 416.20K | 194.13K | 1.41M |
| Gross Profit | 198.78K | 198.78K | 406.29K | 361.87K | -204.55K | 742.98K |
| EBITDA | -2.35M | -2.35M | -1.63M | -2.08M | -12.08M | -2.15M |
| Net Income | -5.28M | -5.28M | -1.73M | -2.16M | -11.42M | -1.58M |
Balance Sheet | ||||||
| Total Assets | 1.32M | 1.32M | 720.21K | 1.44M | 1.69M | 11.10M |
| Cash, Cash Equivalents and Short-Term Investments | 839.50K | 839.50K | 59.65K | 115.07K | 358.43K | 748.05K |
| Total Debt | 302.91K | 302.91K | 444.39K | 731.73K | 17.75K | 24.53K |
| Total Liabilities | 445.61K | 445.61K | 2.66M | 3.08M | 1.08M | 1.05M |
| Stockholders Equity | 872.51K | 872.51K | -1.94M | -1.63M | 604.80K | 10.05M |
Cash Flow | ||||||
| Free Cash Flow | -1.11M | 0 | 233.85K | -279.38K | -1.84M | -1.50M |
| Operating Cash Flow | -2.63M | -2.63M | 233.85K | -279.38K | -1.84M | -1.50M |
| Investing Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | 3.41M | 3.41M | -289.27K | 36.02K | 1.45M | 1.96M |
Skin Elements Limited Peers Comparison
Overall Rating
AU:NUC46Neutral
AU:ZNO45Neutral- AU:SKN41Neutral
AU:EVE38Underperform
AU:MCP38Underperform
AU:HCT29Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 62Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
| AU:NUC | 46Neutral | AUD 12.55M | -1.68 | -88.51% | ― | 11.96% | -81.99% |
| AU:ZNO | 45Neutral | AUD 21.33M | -11.75 | -50.40% | ― | 28.77% | 59.60% |
| AU:SKN | 41Neutral | AUD 6.97M | -0.44 | -430.23% | ― | -50.64% | -72.00% |
| AU:EVE | 38Underperform | AUD 4.76M | -2.11 | -49.07% | ― | -33.53% | 42.98% |
| AU:MCP | 38Underperform | AUD 18.71M | -0.89 | -33.14% | ― | -14.87% | -35.60% |
| AU:HCT | 29Underperform | AUD 12.14M | -3.79 | 1795.70% | ― | 0.72% | -486.96% |
* Consumer Defensive Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| AU:SKN | Skin Elements Limited | ― | ― | ― | |
| AU:MCP | Mcpherson'S Limited | 0.13 | -0.11 | -46.94% | |
| AU:EVE | EVE Health Group Limited | 0.01 | -0.02 | -56.67% | |
| AU:ZNO | Zoono Group Limited | 0.05 | -0.00 | -4.08% | |
| AU:NUC | Nuchev Pty Ltd | 0.08 | -0.06 | -42.86% | |
| AU:HCT | Holista Colltech Limited | 0.03 | -0.04 | -57.69% |
Skin Elements Limited Corporate Events
Skin Elements lodges 2026 preliminary final report and updates corporate details
Skin Elements Limited has released its Appendix 4E preliminary final report and annual report for the year ended 30 June 2026. The filing formalises its governance and reporting framework, confirming the current board, key executives, auditors and sh...
Skin Elements Secures Farmlands Deal and New Funding Amid Board Overhaul
Skin Elements Limited reported a pivotal quarter marked by the signing of an exclusive distribution deal with Farmlands Co-Operative Society in New Zealand for its ECO-Nurture horticultural bio-stimulant. The agreement, following multi-season trials...
Skin Elements seeks ASX quotation for 25 million new shares
Skin Elements Limited has applied for the quotation of 25,000,000 ordinary fully paid shares on the ASX, with an issue date of July 8, 2026. The move formalises the listing of these new securities, supporting the company’s capital structure and...
Skin Elements Secures NZ$600,000 Farmlands Deal for ECO-Nurture in Kiwifruit Sector
Skin Elements has signed an exclusive distribution agreement with New Zealand’s largest farmer-owned rural co-operative, Farmlands, for its ECO-Nurture horticultural bio-stimulant. Farmlands has placed an initial NZ$600,000 order for 4,000 litr...
Skin Elements Requests Trading Halt Ahead of Major Distribution Deal
Skin Elements Limited has requested a trading halt in its securities on the ASX, effective immediately, as it prepares to announce a material distribution agreement. The halt will remain in place until the announcement is released or normal trading r...
Skin Elements Appoints New Director With No Current Shareholding
Skin Elements Limited has appointed Frank Knezovic as a director effective 23 June 2026, according to an initial director’s interest notice lodged with the ASX. At the time of his appointment, Knezovic holds no relevant interests in the company...
Skin Elements files final interest notice as director Stuart Usher exits board
Skin Elements has announced that director Stuart Usher has ceased to serve on the company’s board as of 22 June 2026, triggering a final director’s interest notice under ASX listing rules. The filing confirms that Mr Usher held no securit...
Skin Elements plans placement of up to 25 million new shares
Skin Elements Limited has notified the ASX of a proposed placement of up to 25 million new ordinary fully paid shares. The new securities, to be issued under ASX Listing Rule procedures, are scheduled for issue on 30 June 2026, expanding the company&...
Skin Elements plans major share issue to raise new capital
Skin Elements Limited has notified the ASX of a proposed issue of up to 318 million new fully paid ordinary shares under a placement or similar capital raising structure. The securities, expected to be issued on 16 July 2026, represent a substantial...
Skin Elements raises A$900,000 and reshapes board and investor relations
Skin Elements Limited has secured A$900,000 through a discounted share placement to sophisticated and professional investors, issuing 300 million new shares to bolster its balance sheet and working capital. The funds will be directed towards advancin...
Skin Elements Requests Trading Halt Ahead of Capital Raising
Skin Elements Limited has requested a trading halt in its securities on the ASX as it prepares to announce a capital raising, with the halt effective immediately and set to last until either the announcement is released or normal trading resumes on 2...
Skin Elements refreshes board as shareholders approve new directors at EGM
Skin Elements Limited reported the outcomes of its Extraordinary General Meeting held on 23 June 2026, in which the chair directed all undirected proxies in favour of all resolutions. Three resolutions seeking the removal of directors were withdrawn...
Skin Elements Reshapes Board Following Shareholder-Driven Governance Push
Skin Elements Limited, an ASX-listed natural biotechnology company, develops plant-based and organic formulations for global consumer and industrial markets, including disinfectants, bio-stimulants, sunscreens and therapeutic skincare products. Its p...
Skin Elements seeks ASX quotation for 95 million new shares
Skin Elements Limited has applied for the quotation of 95,000,000 new ordinary fully paid shares on the Australian Securities Exchange, with an issue date of 4 June 2026. The new securities arise from the exercise or conversion of existing options or...
Skin Elements director Peter Malone steps down but retains major indirect stake
Skin Elements has announced that director Peter Malone ceased to be a director on 2 June 2026, with a final disclosure of his interests in the company’s securities. The filing shows Malone held no shares directly, but maintained substantial ind...
Skin Elements director’s options lapse with no change to shareholding
Skin Elements Limited has disclosed a change in director Filippo (Phil) Giglia’s interests following the expiry of certain options. Giglia holds his interests indirectly through Colosseum Securities Pty Ltd, where he is sole director and a bene...
Skin Elements Issues 95 Million New Ordinary Shares After Option Conversions
Skin Elements Limited has notified the market that 95,000,000 ordinary fully paid shares are being issued following the exercise or conversion of previously unquoted securities. The substantial new share issuance will expand the company’s capit...
Skin Elements EGM Yields Split Vote on Board Removals and Governance Changes
Skin Elements Limited has announced the results of its Extraordinary General Meeting held on 2 June 2026, where shareholders voted on several board changes and a constitutional amendment. Resolutions to remove directors Filippo (Phil) Leone Giglia an...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 30, 2026